Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Teladoc (TDOC) Gets a Hold from Barclays

Tipranks - Tipranks - Fri Mar 27, 2:40AM CDT

In a report released today, Peter Warendorf from Barclays maintained a Hold rating on Teladoc, with a price target of $7.00.

Claim 30% Off TipRanks Premium

Warendorf covers the Healthcare sector, focusing on stocks such as Healthequity, Progyny, and Teladoc. According to TipRanks, Warendorf has an average return of -13.2% and a 28.57% success rate on recommended stocks.

In addition to Barclays, Teladoc also received a Hold from J.P. Morgan’s Lisa Gill in a report issued on March 13. However, on March 17, Bank of America Securities maintained a Buy rating on Teladoc (NYSE: TDOC).

See today’s best-performing stocks on TipRanks >>

Based on Teladoc’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $642.27 million and a GAAP net loss of $25.14 million. In comparison, last year the company earned a revenue of $640.49 million and had a GAAP net loss of $48.41 million

Read More on TDOC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).